0001144204-16-101709.txt : 20160513
0001144204-16-101709.hdr.sgml : 20160513
20160513150115
ACCESSION NUMBER: 0001144204-16-101709
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160511
FILED AS OF DATE: 20160513
DATE AS OF CHANGE: 20160513
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alliqua BioMedical, Inc.
CENTRAL INDEX KEY: 0001054274
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 582349413
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1010 STONY HILL ROAD
STREET 2: SUITE 200
CITY: YARDLEY
STATE: PA
ZIP: 19067
BUSINESS PHONE: 215-702-8550
MAIL ADDRESS:
STREET 1: 1010 STONY HILL ROAD
STREET 2: SUITE 200
CITY: YARDLEY
STATE: PA
ZIP: 19067
FORMER COMPANY:
FORMER CONFORMED NAME: Alliqua, Inc.
DATE OF NAME CHANGE: 20101222
FORMER COMPANY:
FORMER CONFORMED NAME: HEPALIFE TECHNOLOGIES INC
DATE OF NAME CHANGE: 20030529
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA CORP
DATE OF NAME CHANGE: 20030219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BARTON BRADFORD
CENTRAL INDEX KEY: 0001618553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36278
FILM NUMBER: 161647840
MAIL ADDRESS:
STREET 1: C/O ALLIQUA BIOMEDICAL, INC.
STREET 2: 2150 CABOT BLVD. WEST
CITY: LANGHORNE
STATE: PA
ZIP: 19047
4
1
v439857_4.xml
OWNERSHIP DOCUMENT
X0306
4
2016-05-11
0
0001054274
Alliqua BioMedical, Inc.
ALQA
0001618553
BARTON BRADFORD
C/O ALLIQUA BIOMEDICAL, INC.
1010 STONY HILL ROAD
YARDLEY
PA
19067
0
1
0
0
Chief Operating Officer
Common Stock
2016-05-11
4
A
0
100000
0
A
245643
D
Represents a restricted stock award that is subject to forfeiture until vested. The award vests in three equal installments based on the Issuer's satisfaction of certain performance criteria prior to May 11, 2021, with one-third (1/3) of the awarded shares vesting on each date, if any, that the Issuer files a report with the SEC reporting audited annual gross revenues that equal or exceed each of $25 million, $30 million and $36 million, subject to the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and the reporting person, effective as of May 11, 2016.
/s/ Bradford Barton
2016-05-13